[Ip-health] Pfizer R&D Unit relocating to China

Outterson, Kevin mko at bu.edu
Wed Mar 16 09:48:52 PDT 2011


The next time that PhRMA or USTR tries to link IP issues in a trade agreement to R&D jobs, ask them about this article from Fierce Biotech:  http://tinyurl.com/5skytn2

Pfizer's R&D unit isn't moving to "high IP" countries with recent trade agreements with PhRMA-inspired IP chapters (Australia, Korea, Singapore, Jordan, etc.) but to China.  The move has nothing to do with IP rules in China.

Kevin Outterson
-------------------
Associate Professor
BU Law & BU SPH
Editor in Chief, Journal of Law, Medicine & Ethics
www.theincidentaleconomist.com<http://www.theincidentaleconomist.com>






More information about the Ip-health mailing list